Skip to main content

Table 1 Socio-demographic and baseline clinical information of clients in the cART, Gurage zone, 2019

From: The effect of “universal test and treat” program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia

VariablesOutcome by program
UTT (N, %)CD4 based (N, %)Total
DiedCensoredDiedCensored(N, %)
Mean age at DX35 ± 8.9 35.4 ± 9.3 35 ± 9.3
Mean weight53 ± 12 51 ± 10 52.16 ± 11.2
Sex
 Male4 (33.3)76 (39.6)16 (44.5)68 (26)164 (32.8)
 Female8 (66.7)116 (60.4)20 (55.5)192 (74)336 (67.2)
Residence
 Rural8 (66.7)58 (30.2)28 (77.8)126 (48.5)220 (44)
 Urban4 (33.3)134 (69.8)8 (22.2)134 (51.5)280 (56)
Marital status
 Single2 (16.7)26 (13.5)2 (5)48 (18.5)78 (15.6)
 Married4 (33.3)110 (57.3)18 (50)132 (50.75)264 (52.8)
 Divorced6 (50)56 (29.2)16 (45)80 (30.75)158 (31.6)
Educational status
 Illiterate10 (83.3)64 (33.3)16 (44.5)94 (36)184 (36.8)
 Literate2 (16.7)128 (66.7)20 (55.5)166 (64)316 (63.2)
WHO stage
 Stage I0 (0)80 (41.6)4 (11.1)34 (13)118 (23.6)
 Stage II4 (33.3)64 (33.4)0 (0)60 (23)128 (25.6)
 Stage III8 (66.7)36 (18.75)30 (83.3)156 (60)230 (46)
 Stage IV0 (0)12 (6.25)2 (5.6)10 (4)24 (4.8)
Median CD4 count257.5 (IQR: 129–560)182 (IQR: 110–234.5)198 (IQR: 125–302)
Median time from diagnosis to Rx0.3 (IQR = 0.1–4.1)0.9 (IQR = 0.6–1.5)0.7 (IQR = 0.2–1.1)
OIS
 Yes4 (33.3)74 (38.5)24 (66.7)140 (53.8)242 (48.4)
 No8 (66.7)118 (61.5)12 (33.3)120 (46.2)258 (51.6)
New OIS
 Yes6 (50)18 (9.4)6 (16.7)10 (3.84)40 (1.6)
 No6 (50)174 (90.6)30 (83.3)250 (96.16)460 (98.4)
Treatment failure
 Yes8 (66.7)10 (5.2)10 (27.8)2 (0.8)30 (6)
 No4 (33.3)182 (94.8)26 (62.2)258 (99.2)470 (94)
Treatment switch
 Yes0 (0)2 (1)2 (5.5)4 (1.54)8 (1.6)
 No12 (100)190 (99)34 (94.5)256 (98.46)492 (98.4)